Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 19 of 19 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company AimMax Therapeutics Inc. | Activity: Research and Development | Company Description AimMax Therapeutics researches and develops biopharmaceuticals for the treatment of infection, inflammation and pain through in-licensing or co-development with strategic partners. | Location Durham |
| |
Company AlphaVax Inc. | Activity: Research and Development | Company Description AlphaVax develops vaccine technology with applications in infectious disease, cancer and biodefense threats. | Location Research Triangle Park |
| |
Company Collaborations Pharmaceuticals Inc. | Activity: Contract Research and Testing | Company Description Collaborations Pharmaceuticals develops drugs for rare and neglected diseases using machine learning software, providing preclinical and clinical expertise to rare disease foundations, academic scientists and companies developing clinical candidates. Collaborations also provides machine learning expertise and software to consumer product and agrochemical companies. | Location Raleigh |
| |
Company Endacea Diagnostics Inc. | Activity: Research and Development | Company Description Endacea Diagnostics is developing EndaTox IVD, an in vitro sepsis diagnostic, and EndaTox Test, an assay to measure LPS endotoxin in biological and non-biological samples. | Location Research Triangle Park |
| |
Company Endacea Inc. | Activity: Research and Development | Company Description Endacea develops A1 adenosine receptor antagonists as drug candidates for cancer, COVID-19 acute lung injury, sepsis and acute renal failure. | Location Research Triangle Park |
| |
Company Extrel Therapeutics Inc. | Activity: Research and Development | Company Description Extrel Therapeutics is developing medical devices to protect patients from post-operative infection, pain and inflammation. | Location Raleigh |
| |
Company Galaxy Diagnostics Inc. | Activity: Contract Research and Testing | Company Description Galaxy Diagnostics offers advanced molecular and serology testing for hard-to-detect flea- and tick-borne infections. It serves physicians, veterinarians and clinical researchers. | Location Durham |
| |
Company Gusto Global LLC | Activity: Research and Development | Company Description Gusto Global is developing a discovery platform that integrates advanced computational and lab-based discovery tools to develop next-generation microbiome-based therapeutics & diagnostics. | Location Research Triangle Park |
| |
Company MultiSeq Inc. | Activity: Research and Development | Company Description MultiSeq out-licenses molecular diagnostics platform technologies for cancer and infectious disease diagnosis. | Location Greensboro |
| |
Company Mycosynthetix Inc. | Activity: Research and Development | Company Description Mycosynthetix manages a large collection of fungal isolates and discovers novel fungal metabolites for human and animal health and compounds for agricultural applications. | Location Hillsborough |
| |
Company PhotoCide Protection Inc. | Activity: Research and Development | Company Description PhotoCide Protection develops self-disinfecting materials based on technology combining engineered cellulose with photosensitizers which emit singlet oxygen, an environmentally-friendly biocidal agent which destroys pathogens on surfaces. | Location Apex |
| |
Company RAIN Scientific Inc. | Activity: Research and Development | Company Description Rain Scientific is developing technologies to combat pathogens such as COVID-19 and drug resistant bacteria. | Location Cornelius |
| |
Company Regennova Inc. | Activity: Research and Development | Company Description Regennova develops therapeutics for inflammatory diseases and neurological disorders, including cerebral stroke, traumatic brain injury, Alzheimer's and sepsis. | Location Durham |
| |
Company Resilient Biotics Inc. | Activity: Research and Development | Company Description Resilient Biotics is developing non-antibiotic, microbiome-based therapeutics to combat complex respiratory infections with applications in human and animal health. Resilient utilizes a proprietary discovery platform for product development and has a broad pipeline across multiple species. | Location Durham |
| |
Company Resonantia Diagnostics | Activity: Research and Development | Company Description Resonantia Diagnostics is a startup developing a point of care diagnostic platform that rapidly identifies a pathogen from a clinical specimen and determines the pathogen's antimicrobial susceptibility. | Location Durham |
| |
Company Synoxa Sciences Inc. | Activity: Research and Development | Company Description Synoxa Sciences develops small molecule therapeutics to treat multi-drug resistant (MDR) bacterial pathogens, including those in the biofilm state. | Location Raleigh |
| |
Company Trana Discovery Inc. | Activity: Research and Development | Company Description Trana Discovery provides an anti-infective discovery platform that enables its partners to identify novel treatments with pathogen-focused spectrums of activity for bacterial, viral and fungal infectious diseases by inhibiting tRNA not possessed by humans or crops. | Location Cary |
| |
Company ValanBio Therapeutics Inc. | Activity: Research and Development | Company Description Valanbio Therapeutics is an early-stage anti-infectives company. Valanbio is developing novel antibiotics for Gram-negative organisms. | Location Durham |
| |
Company Vero Diagnostics LLC | Activity: Contract Research and Testing | Company Description Vero Diagnostics offers comprehensive diagnostic testing, including urine and oral fluid drug monitoring, pathogen detection, Pharmacogenomics (PGx) testing and blood testing. | Location Apex |